Boston Partners’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.89M Buy
80,278
+15,168
+23% +$835K ﹤0.01% 511
2026
Q1
$2.9M Buy
65,110
+14,971
+30% +$591K ﹤0.01% 538
2025
Q4
$1.92M Buy
+50,139
New +$1.71M ﹤0.01% 567
2025
Q1
Sell
-78,855
Closed -$2.46M 776
2024
Q4
$2.46M Buy
78,855
+1,776
+2% +$49.7K ﹤0.01% 474
2024
Q3
$1.82M Buy
77,079
+21,504
+39% +$480K ﹤0.01% 527
2024
Q2
$1.11M Buy
+55,575
New +$1.09M ﹤0.01% 573

Other funds holding MRX

Boston Partners's MRX Position: Q2 2026 in Review

Boston Partners increased its Marex Group Limited Ordinary Shares (MRX) stake by 23% in Q2 2026, buying an estimated $835K and bringing the position to 80,278 shares worth $4.89M. The position accounts for ﹤0.01% of the portfolio, ranked #511.

Boston Partners first reported a position in MRX in Q2 2024 and has held it in 6 quarters since. 154 funds tracked by Wall St. Rank hold MRX as of Q2 2026.

  • Boston Partners held 80,278 shares of Marex Group Limited Ordinary Shares worth $4.89M as of Q2 2026.
  • Boston Partners bought 15,168 Marex Group Limited Ordinary Shares shares in Q2 2026, an estimated $835K.
  • Marex Group Limited Ordinary Shares made up ﹤0.01% of Boston Partners's portfolio in Q2 2026, its #511 holding.
  • Boston Partners first reported a position in Marex Group Limited Ordinary Shares in Q2 2024 and has held it in 6 quarters since.
  • 154 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.